Wibis Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Hanol BioPharma Co., Ltd.
MFDS item code 201404232 · Approved 2014.09.16
This product's status changed to Approval withdrawn on 2023.12.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (gastric and duodenal ulcers, gastritis, etc.); prevention of Mendelson syndrome
This medication is used to treat ulcers that occur in the stomach and duodenum as well as gastritis. It is also effective in treating Zollinger-Ellison syndrome and gastroesophageal reflux disease. It helps prevent Mendelson syndrome by administering the medication before surgery, and also prevents the occurrence of ulcers after surgery. It is used to prevent and treat ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). This medication is utilized for improving various gastrointestinal disorders.
○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets per dose twice daily, in the morning and at bedtime. The same dosage applies when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets per dose twice daily or 4 tablets once daily at bedtime for 8 weeks. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose three times daily, and increase the dose if necessary. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Pre-anesthetic medication (prevention of Mendelson's syndrome) Give 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is preferable to also give 2 tablets per dose on the night before surgery.
This medication should not be used in patients undergoing dialysis or those who have had allergic reactions to this medication or its components. It is also not safe for patients with a history of acute porphyria, impaired kidney function, a history of upper gastrointestinal surgery, pregnant women or those who could become pregnant, premature infants and neonates, and patients on potassium-restricted diets. Patients with liver function problems, a history of drug allergies, the elderly, and those with a history of kidney dysfunction should use this medication with special caution. When taken with non-steroidal anti-inflammatory drugs, especially elderly patients or those with a history of peptic ulcers should undergo regular monitoring. This medication can mask symptoms of stomach cancer, so patients with gastric ulcers or those over middle age who have newly developed dyspeptic symptoms should ensure they do not have a malignant disease before administration. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo bacterial eradication therapy. Patients in severe intensive care or those with hypophosphatemia, as well as those experiencing swallowing difficulties, require careful attention. Rarely, serious allergic reactions like anaphylaxis shock may occur during the use of this medication, so symptoms should be carefully observed. If hypersensitivity reactions such as skin rashes, urticaria, angioedema, fever, bronchospasm, hypotension, or chest pain occur, the use of this medication should be stopped immediately. Blood-related abnormalities such as granulocytopenia, leukopenia, and thrombocytopenia may occur rarely, and blood tests should be performed if symptoms like general fatigue, bleeding, or fever develop. Symptoms of liver dysfunction such as temporary elevation of liver enzymes or hepatitis may appear, warranting regular liver function tests and symptom monitoring. Cardiovascular issues, including arrhythmias and vasculitis, have also been reported very rarely. Gastrointestinal side effects may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and the color of stool may change; these do not require separate treatment unless specified. Neurological side effects such as dizziness, drowsiness, confusion, seizures, insomnia, or headaches can occur rarely, so patients should consult medical personnel if they experience abnormal symptoms. Musculoskeletal side effects like myalgia or arthralgia can occur rarely, and in severe cases, rhabdomyolysis may occur, necessitating caution. Dermatological side effects such as rashes and hair loss have been reported rarely, and serious skin reactions may occur. Long-term use should be avoided, and treatment progress should be carefully monitored, with periodic blood tests and checks of liver and kidney function recommended. Elderly patients or those with chronic lung disease, diabetes, or weakened immunity may have an increased risk of pneumonia. Patients should avoid driving or operating dangerous machinery if they experience dizziness or drowsiness while taking this medication. Interactions with other drugs may occur, so patients, especially those on anticoagulants or certain antibiotics and anticonvulsants, should consult with medical personnel. It is safest for pregnant or breastfeeding women not to use this medication; safety in pediatric patients has not been established, so administration is not recommended. In cases of overdose, emergency measures such as vomiting or gastric lavage may be required, and blood dialysis may be necessary to remove the drug if needed. This medication may reduce gastric acid secretion and promote bacterial growth in the gastrointestinal tract, so regular examinations including eye checks are necessary during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and should be kept at a temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the medication will be well maintained and deterioration can be prevented.
This medication is a round, white film-coated tablet.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Hanol BioPharma Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.